|
1
|
Kapravelou G, Martinez R, Andrade AM,
Nebot E, Camiletti-Moiron D, Aparicio VA, Lopez-Jurado M, Aranda P,
Arrebola F, Fernandez-Segura E, et al: Aerobic interval exercise
improves parameters of nonalcoholic fatty liver disease (NAFLD) and
other alterations of metabolic syndrome in obese Zucker rats. Appl
Physiol Nutr Metab. 40:2860–1252. 2015. View Article : Google Scholar
|
|
2
|
Eckel RH, Grundy SM and Zimmet PZ: The
metabolic syndrome. Lancet. 365:1415–1428. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Eckel RH, Alberti KG, Grundy SM and Zimmet
PZ: The metabolic syndrome. Lancet. 375:181–183. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kaur J: A comprehensive review on
metabolic syndrome. Cardiol Res Pract. 2014:9431622014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Younossi ZM, Koenig AB, Abdelatif D, Fazel
Y, Henry L and Wymer M: Global epidemiology of nonalcoholic fatty
liver disease-meta-analytic assessment of prevalence, incidence,
and outcomes. Hepatology. 64:73–84. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bugianesi E, Leone N, Vanni E, Marchesini
G, Brunello F, Carucci P, Musso A, De Paolis P, Capussotti L,
Salizzoni M and Rizzetto M: Expanding the natural history of
nonalcoholic steatohepatitis: From cryptogenic cirrhosis to
hepatocellular carcinoma. Gastroenterology. 123:134–140. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Marchesini G, Bugianesi E, Forlani G,
Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N,
Melchionda N and Rizzetto M: Nonalcoholic fatty liver,
steatohepatitis, and the metabolic syndrome. Hepatology.
37:917–923. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lonardo A, Ballestri S, Marchesini G,
Angulo P and Loria P: Nonalcoholic fatty liver disease: A precursor
of the metabolic syndrome. Dig Liver Dis. 47:181–190. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Younossi ZM, Stepanova M, Afendy M, Fang
Y, Younossi Y, Mir H and Srishord M: Changes in the prevalence of
the most common causes of chronic liver diseases in the United
States from 1988 to 2008. Clin Gastroenterol Hepatol. 9:524–530.e1.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sanyal AJ, Campbell-Sargent C, Mirshahi F,
Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML and Clore
JN: Nonalcoholic steatohepatitis: association of insulin resistance
and mitochondrial abnormalities. Gastroenterology. 120:1183–1192.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Browning JD and Horton JD: Molecular
mediators of hepatic steatosis and liver injury. J Clin Invest.
114:147–152. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tang A, Desai A, Hamilton G, Wolfson T,
Gamst A, Lam J, Clark L, Hooker J, Chavez T, Ang BD, et al:
Accuracy of MR imaging-estimated proton density fat fraction for
classification of dichotomized histologic steatosis grades in
nonalcoholic fatty liver disease. Radiology. 274:416–425. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sanyal AJ and Pacana T: A lipidomic
readout of disease progression in a diet-induced mouse model of
nonalcoholic fatty liver disease. Trans Am Clin Climatol Assoc.
126:271–288. 2015.PubMed/NCBI
|
|
14
|
Tsatsoulis A, Mantzaris MD, Bellou S and
Andrikoula M: Insulin resistance: An adaptive mechanism becomes
maladaptive in the current environment-an evolutionary perspective.
Metabolism. 62:622–633. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Valenzuela R and Videla LA: The importance
of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in
development of non-alcoholic fatty liver associated with obesity.
Food Funct. 2:644–648. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim D, Touros A and Kim WR: Nonalcoholic
fatty liver disease and metabolic syndrome. Clin Liver Dis.
22:133–140. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chalasani N, Younossi Z, Lavine JE, Diehl
AM, Brunt EM, Cusi K, Charlton M and Sanyal AJ: The diagnosis and
management of non-alcoholic fatty liver disease: Practice guideline
by the American association for the study of liver diseases,
American college of gastroenterology, and the american
gastroenterological association. Hepatology. 55:2005–2023. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hickman I and Macdonald G: Is vitamin E
beneficial in chronic liver disease? Hepatology. 46:288–290. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sanyal AJ, Mofrad PS, Contos MJ, Sargeant
C, Luketic VA, Sterling RK, Stravitz RT, Shiffman ML, Clore J and
Mills AS: A pilot study of vitamin E versus vitamin E and
pioglitazone for the treatment of nonalcoholic steatohepatitis.
Clin Gastroenterol Hepatol. 2:1107–1115. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chalasani N, Younossi Z, Lavine JE,
Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM and Sanyal AJ:
The diagnosis and management of nonalcoholic fatty liver disease:
Practice guidance from the American association for the study of
liver diseases. Hepatology. 67:328–357. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Juurlink DN, Gomes T, Lipscombe LL, Austin
PC, Hux JE and Mamdani MM: Adverse cardiovascular events during
treatment with pioglitazone and rosiglitazone: Population based
cohort study. BMJ. 339:b29422009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hossain N, Kanwar P and Mohanty SR: A
comprehensive updated review of pharmaceutical and
nonpharmaceutical treatment for NAFLD. Gastroenterol Res Pract.
2016:71092702016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gee PT: Unleashing the untold and
misunderstood observations on vitamin E. Genes Nutr. 6:5–16. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bjelakovic G, Nikolova D, Gluud LL,
Simonetti RG and Gluud C: Mortality in randomized trials of
antioxidant supplements for primary and secondary prevention:
Systematic review and meta-analysis. JAMA. 297:842–857. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nicolson GL, de Mattos GF, Settineri R,
Costa C, Ellithorpe R, Rosenblatt S, La Valle J, Jimenez A and Ohta
S: Clinical Effects of Hydrogen Administration: From Animal and
Human Diseases to Exercise Medicine. Int J Clin Med. 7:322016.
View Article : Google Scholar
|
|
26
|
Dole M, Wilson FR and Fife WP: Hyperbaric
hydrogen therapy: A possible treatment for cancer. Science.
190:152–154. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ohsawa I, Ishikawa M, Takahashi K,
Watanabe M, Nishimaki K, Yamagata K, Katsura K, Katayama Y, Asoh S
and Ohta S: Hydrogen acts as a therapeutic antioxidant by
selectively reducing cytotoxic oxygen radicals. Nat Med.
13:688–694. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Song G, Li M, Sang H, Zhang L, Li X, Yao
S, Yu Y, Zong C, Xue Y and Qin S: Hydrogen-rich water decreases
serum LDL-cholesterol levels and improves HDL function in patients
with potential metabolic syndrome. J Lipid Res. 54:1884–1893. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Song G, Tian H, Qin S, Sun X, Yao S, Zong
C, Luo Y, Liu J, Yu Y, Sang H and Wang X: Hydrogen decreases
athero-susceptibility in apolipoprotein B-containing lipoproteins
and aorta of apolipoprotein E knockout mice. Atherosclerosis.
221:55–65. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zong C, Song G, Yao S, Li L, Yu Y, Feng L,
Guo S, Luo T and Qin S: Administration of hydrogen-saturated saline
decreases plasma low-density lipoprotein cholesterol levels and
improves high-density lipoprotein function in high-fat diet-fed
hamsters. Metabolism. 61:794–800. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Song G, Zong C, Zhang Z, Yu Y, Yao S, Jiao
P, Tian H, Zhai L, Zhao H, Tian S, et al: Molecular hydrogen
stabilizes atherosclerotic plaque in low-density lipoprotein
receptor-knockout mice. Free Radic Biol Med. 87:58–68. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Choi K, Kim H, Hee S, Jin S and Yi H:
Neuroprotective effects of hydrogen inhalation in an experimental
rat intracerebral hemorrhage model. Brain Res Bull. 142:122–128.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang L, Zhao C, Wu S, Xiao G, Zhuge X, Lei
P and Xie K: Hydrogen gas treatment improves the neurological
outcome after traumatic brain injury via increasing miR-21
expression. Shock. 50:308–315. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhou H, Fu Z, Wei Y, Liu J, Cui X, Yang W,
Ding W, Pan P and Li W: Hydrogen inhalation decreases lung graft
injury in brain-dead donor rats. J Heart Lung Transpl. 32:251–258.
2013. View Article : Google Scholar
|
|
36
|
Chen O, Cao Z, Li H, Ye Z, Zhang R, Zhang
N, Huang J, Zhang T, Wang L, Han L, et al: High-concentration
hydrogen protects mouse heart against ischemia/reperfusion injury
through activation of the PI3K/Akt1 pathway. Sci Rep. 7:148712017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li H, Chen O, Ye Z, Zhang R, Hu H, Zhang
N, Huang J, Liu W and Sun X: Inhalation of high concentrations of
hydrogen ameliorates liver ischemia/reperfusion injury through A2A
receptor mediated PI3K-Akt pathway. Biochem Pharmacol. 130:83–92.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
He Y, Shi JZ, Zhang RJ, Zhai DX, Zhang D,
Yu CQ and Liu YH: Effects of hydrogen gas inhalation on
endometriosis in rats. Reprod Sci. 24:324–331. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Peng Z, Chen W, Wang L, Ye Z, Gao S, Sun X
and Guo Z: Inhalation of hydrogen gas ameliorates
glyoxylate-induced calcium oxalate deposition and renal oxidative
stress in mice. Int J Clin Exp Pathol. 8:2680–2689. 2015.PubMed/NCBI
|
|
40
|
Chen JB, Kong XF, Lv YY, Qin SC, Sun XJ,
Mu F, Lu TY and Xu KC: ‘Real world survey’ of hydrogen-controlled
cancer: A follow-up report of 82 advanced cancer patients. Med Gas
Res. 9:1152019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Panchal SK and Brown L: Rodent models for
metabolic syndrome research. J Biomed Biotechnol.
2011:3519822010.PubMed/NCBI
|
|
42
|
Nakao A, Toyoda Y, Sharma P, Evans M and
Guthrie N: Effectiveness of hydrogen rich water on antioxidant
status of subjects with potential metabolic syndrome-an open label
pilot study. J Clin Biochem Nutr. 46:140–149. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hashimoto M, Katakura M, Nabika T, Tanabe
Y, Hossain S, Tsuchikura S and Shido O: Effects of hydrogen-rich
water on abnormalities in a SHR Cg-Lepr cp/NDmcr rat-a metabolic
syndrome rat model. Med Gas Res. 1:262011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Korovljev D, Trivic T, Drid P and Ostojic
S: Molecular hydrogen affects body composition, metabolic profiles,
and mitochondrial function in middle-aged overweight women. Ir J
Med Sci. 187:85–89. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhai X, Chen X, Lu J, Zhang Y, Sun X,
Huang Q and Wang Q: Hydrogen-rich saline improves non-alcoholic
fatty liver disease by alleviating oxidative stress and activating
hepatic PPARα and PPARγ. Mol Med Rep. 15:1305–1312. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Panchal SK, Poudyal H, Iyer A, Nazer R,
Alam MA, Diwan V, Kauter K, Sernia C, Campbell F, Ward L, et al:
High-carbohydrate high-fat diet-induced metabolic syndrome and
cardiovascular remodeling in rats. J Cardiovasc Pharmacol.
57:611–624. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang O, Liu J, Cheng Q, Guo X, Wang Y,
Zhao L, Zhou F and Ji B: Effects of ferulic acid and γ-oryzanol on
high-fat and high-fructose diet-induced metabolic syndrome in rats.
PLoS One. 10:e01181352015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tu LN, Showalter MR, Cajka T, Fan S,
Pillai VV, Fiehn O and Selvaraj V: Metabolomic characteristics of
cholesterol-induced non-obese nonalcoholic fatty liver disease in
mice. Sci Rep. 7:61202017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yetukuri L, Katajamaa M, Medina-Gomez G,
Seppänen-Laakso T, Vidal-Puig A and Orešič M: Bioinformatics
strategies for lipidomics analysis: characterization of obesity
related hepatic steatosis. BMC Syst Biol. 1:122007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sanders F, McNally B and Griffin JL: Blood
triacylglycerols: A lipidomic window on diet and disease. Biochem
Soc Tran. 44:638–644. 2016. View Article : Google Scholar
|
|
51
|
Hernández-Rodas MC, Valenzuela R,
Echeverría F, Rincón-Cervera MA, Espinosa A, Illesca P, Muñoz P,
Corbari A, Romero N, Gonzalez-Mañan D and Videla LA:
Supplementation with docosahexaenoic acid and extra virgin olive
oil prevents liver steatosis induced by a high-fFat diet in mice
through PPAR-α and Nrf2 upregulation with concomitant SREBP-1c and
NF-kB downregulation. Mol Nutr Food Res. 61:2017. View Article : Google Scholar
|
|
52
|
Echeverría F, Valenzuela R, Espinosa A,
Bustamante A, Álvarez D, Gonzalez-Mañan D, Ortiz M, Soto-Alarcon SA
and Videla LA: Reduction of high-fat diet-induced liver
proinflammatory state by eicosapentaenoic acid plus hydroxytyrosol
supplementation: Involvement of resolvins RvE1/2 and RvD1/2. J Nutr
Biochem. 63:35–43. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kawai D, Takaki A, Nakatsuka A, Wada J,
Tamaki N, Yasunaka T, Koike K, Tsuzaki R, Matsumoto K, Miyake Y, et
al: Hydrogen-rich water prevents progression of nonalcoholic
steatohepatitis and accompanying hepatocarcinogenesis in mice.
Hepatology. 56:912–921. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Iio A and Ito M, Itoh T, Terazawa R,
Fujita Y, Nozawa Y, Ohsawa I, Ohno K and Ito M: Molecular hydrogen
attenuates fatty acid uptake and lipid accumulation through
downregulating CD36 expression in HepG2 cells. Med Gas Res.
3:62013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ahmed MH and Byrne CD: Modulation of
sterol regulatory element binding proteins (SREBPs) as potential
treatments for non-alcoholic fatty liver disease (NAFLD). Drug
Discov Today. 12:740–747. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Aragno M, Tomasinelli CE, Vercellinatto I,
Catalano MG, Collino M, Fantozzi R, Danni O and Boccuzzi G:
SREBP-1c in nonalcoholic fatty liver disease induced by
Western-type high-fat diet plus fructose in rats. Free Radical Bio
Med. 47:1067–1074. 2009. View Article : Google Scholar
|
|
57
|
Valenzuela R and Videla LA: Impact of the
co-administration of N-3 fatty acids and olive oil components in
preclinical nonalcoholic fatty liver disease models: A mechanistic
view. Nutrients. 12:4992020. View Article : Google Scholar
|
|
58
|
Paquette A, Wang D, Jankowski M, Gutkowska
J and Lavoie JM: Effects of ovariectomy on PPAR alpha, SREBP-1c,
and SCD-1 gene expression in the rat liver. Menopause.
15:1169–1175. 2008. View Article : Google Scholar : PubMed/NCBI
|
